DEF 14A

Company

FENNEC PHARMACEUTICALS INC.

Filed

May 25, 2021

Period of Report

June 29, 2021

Accession Number

0001104659-21-071417

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →